Brief: Medavail Posts Quarterly Loss Per Share Of $0.32
Aug 11 (Reuters) - MedAvail Holdings Inc MDVL.O :
* MEDAVAIL REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS
* Q2 SALES ROSE 118 PERCENT TO $5.0 MILLION
* REVISED ITS 2021 NET REVENUE GUIDANCE EXPECTATION FROM THE
PRIOR
RANGE OF BETWEEN $27 TO $31 MILLION TO AT LEAST $21 MILLION.
* IDENTIFIED 10 CLINICS THAT DO NOT MEET EXPECTATIONS GOING
FORWARD
* HAVE DECIDED TO EXIT SOME SITES PRIOR TO 2021 YEAR-END
* QTRLY LOSS PER SHARE $0.32
Source text for Eikon: ID:nBwbTJ9Ksa
Further company coverage: MDVL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medavail Holdings
See all newsBrief: Medavail Holdings Approved Reduction In Force Of About 40% Of Current Full-Time Employees
Brief: MedAvail Announces Agreement With New Orleans-Based St. Thomas Community Health Centers For Deployment Of Two M4 Medcenters
Brief: Medavail Announces Agreement With ASP Cares For Deployment Of Ten M4 Medcenters
Brief: MedAvail Announces Agreement With Oak Lawn Pharmacy For Deployment M4 Medcenters
Brief: Medavail Announces 1-For-50 Reverse Stock Split